Novel methods to estimate antiretroviral adherence: protocol for a longitudinal study

Novel methods to estimate antiretroviral adherence: protocol for a longitudinal study

Parya Saberi, Kristin Ming, Dominique Legnitto, Torsten B Neilands, Monica Gandhi, Mallory O Johnson Department of Medicine, University of California San Francisco, San Francisco, CA, USA Background: There is currently no gold standard for assessing antiretroviral (ARV) adherence, so researchers o...

Full description

Bibliographic Details
Main Authors:	Saberi P, Ming K, Legnitto D, Neilands TB, Gandhi M, Johnson MO
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-06-01
Series:	Patient Preference and Adherence
Subjects:	adherence assessment HIV hair measures pill counts pharmacy refills remote study text message antiretroviral therapy PrEP
Online Access:	https://www.dovepress.com/novel-methods-to-estimate-antiretroviral-adherence-protocol-for-a-long-peer-reviewed-article-PPA

Similar Items

What's new for antiretroviral treatment in women with HIV
by: Nisha Andany, et al.
Published: (2016-04-01)

Injectable Antiretroviral Drugs: Back to the Future
by: Marco Berruti, et al.
Published: (2021-02-01)

Application of a composite measure of product adherence, protocol compliance, and semen exposure to a phase III microbicide HIV prevention trial
by: Terry A. Jacot, et al.
Published: (2021-09-01)

Adherence to Antiretroviral Medicines Among Adolescents and Young Adults in Benue State, Nigeria
by: Tor-Anyiin, Amom
Published: (2018)

Development and clinical assessment of new objective adherence markers for four microbicide delivery systems used in HIV prevention studies
by: Terry A. Jacot, et al.
Published: (2018-11-01)

Long-term adherence to antiretroviral therapy in a South African adult patient cohort: a retrospective study
by: Atika Moosa, et al.
Published: (2019-09-01)

Changing the PrEP Narrative: A Call to Action to Increase PrEP Uptake among Women
by: Alina Cernasev, et al.
Published: (2021-06-01)

Adherence to recommendations for ART and targeted PrEP use among HIV serodiscordant couples in East Africa: the “PrEP as a bridge to ART” strategy
by: Nicholas Musinguzi, et al.
Published: (2020-10-01)

Editorial: Pharmacokinetics and Pharmacodynamics of Pre-Exposure Prophylaxis Against HIV
by: Max von Kleist, et al.
Published: (2020-08-01)

Associations between perceived barriers and benefits of using HIV pre-exposure prophylaxis and medication adherence among men who have sex with men in Western China
by: Ying Hu, et al.
Published: (2018-11-01)

Failure of pre-exposure prophylaxis with daily tenofovir/emtricitabine and the scenario of delayed HIV seroconversion
by: Shui-Shan Lee, et al.
Published: (2020-05-01)

A qualitative exploration to understand barriers and facilitators to daily oral PrEP uptake and sustained adherence among HIV-negative women planning for or with pregnancy in rural Southwestern Uganda
by: Atukunda, E.C, et al.
Published: (2022)

Impact of pharmacist-directed counseling and message reminder services on medication adherence and clinical outcomes in type 2 diabetes mellitus
by: Narayana Goruntla, et al.
Published: (2019-01-01)

Integrating Oral PrEP Into Family Planning Services for Women in Sub-saharan Africa: Findings From a Multi-Country Landscape Analysis
by: Neeraja Bhavaraju, et al.
Published: (2021-06-01)

“PrEP”ing for a PrEP demonstration project: understanding PrEP knowledge and attitudes among cisgender women
by: Elizabeth C. Pasipanodya, et al.
Published: (2021-05-01)

Predictors of non adherence to antiretroviral therapy at an urban HIV care and treatment center in Tanzania
by: Sangeda RZ, et al.
Published: (2018-08-01)

Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011
by: Ruffin Nicolas, et al.
Published: (2012-07-01)

Nonadherence to antiretroviral therapy among people living with HIV/AIDS attending two tertiary care hospitals in district of northern India
by: Mukesh Shukla, et al.
Published: (2016-01-01)

Substance Use and Adherence to HIV Preexposure Prophylaxis for Men Who Have Sex with Men
by: Martin Hoenigl, et al.
Published: (2018-12-01)

Design of a care pathway for pharmacy-based PrEP delivery in Kenya: results from a collaborative stakeholder consultation
by: Katrina F. Ortblad, et al.
Published: (2020-11-01)

The Promise of the Dual Prevention Pill: A Framework for Development and Introduction
by: Barbara A. Friedland, et al.
Published: (2021-06-01)

Effects of telephonic SMS reminders influence on adherence to scheduled medication pick up appointments among adults on antiretrovirals at the Swakopmund State Hospital ART clinic Namibia
by: Ugburo, Emmanuel Oritseweyinmi
Published: (2016)

Is PrEP necessary during natural conception in HIV-1-serodiscordant couples on ART with suppressed viral load? A retrospective cohort analysis
by: Lijun Sun, et al.
Published: (2020-03-01)

Telemedicine as a tool for PrEP delivery during the COVID-19 pandemic in a large HIV prevention service in Rio de Janeiro-Brazil
by: Brenda Hoagland, et al.
Published: (2020-07-01)

Acceptability of pre-exposure prophylaxis for HIV prevention: facilitators, barriers and impact on sexual risk behaviors among men who have sex with men in Benin
by: Carin Ahouada, et al.
Published: (2020-08-01)

Protocol for an HIV Pre-exposure Prophylaxis (PrEP) Population Level Intervention Study in Victoria Australia: The PrEPX Study
by: Kathleen E. Ryan, et al.
Published: (2018-05-01)

Portuguese health care providers’ knowledge, attitudes, and acceptability of HIV pre-exposure prophylaxis
by: Rui Baptista-Gonçalves, et al.
Published: (2018-11-01)

The relevance of pre-exposure prophylaxis in gay men’s lives and their motivations to use it: a qualitative study
by: Jorge L. Alcantar Heredia, et al.
Published: (2021-10-01)

Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate
by: Tim R. Cressey, et al.
Published: (2020-08-01)

The Association between Sexual Behavior and Adherence to Hiv Pre-exposure Prophylaxis Medication in Hiv Serodiscordant Couples
by: Kintu, Alexander
Published: (2013)

Predictors of mHealth use in promoting adherence to pre-exposure prophylaxis among female sex workers: an evaluation of the Jichunge intervention in Dar es Salaam, Tanzania
by: Kazaura, M., et al.
Published: (2022)

Update on microbicide research and development-seeking new HIV prevention tools for women
by: Mertenskoetter T, et al.
Published: (2011-01-01)

Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines. Update April 2018
by: Edwina Wright, et al.
Published: (2018-07-01)

Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP)
by: Hongyi Wang, et al.
Published: (2019-08-01)

Modeling HIV Pre-Exposure Prophylaxis
by: Thomas Straubinger, et al.
Published: (2020-01-01)

HIV seroconversion during pregnancy and the need for pre-exposure prophylaxis (PrEP)
by: Zorrilla CD, et al.
Published: (2018-04-01)

Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines
by: Edwina Wright, et al.
Published: (2017-07-01)

Alcohol consumption, substance use, and depression in relation to HIV Pre-Exposure Prophylaxis (PrEP) nonadherence among gay, bisexual, and other men-who-have-sex-with-men
by: Paul A. Shuper, et al.
Published: (2020-11-01)

Monitoring HIV testing and pre-exposure prophylaxis information seeking by combining digital and traditional data
by: Derek C. Johnson, et al.
Published: (2021-02-01)

Comparing Self-Report Pre-Exposure Prophylaxis Adherence Questions to Pharmacologic Measures of Recent and Cumulative Pre-Exposure Prophylaxis Exposure
by: Jill Blumenthal, et al.
Published: (2019-07-01)